Publication

Sleep Disturbance in Dementia with Lewy Bodies and Alzheimer's Disease: A Multicenter Analysis

Downloadable Content

Persistent URL
Last modified
  • 02/20/2025
Type of Material
Authors
    Donald Bliwise, Emory UniversityNathaniel D. Mercaldo, University of WashingtonAlon Y. Avidan, University of California Los AngelesBradley F. Boeve, Mayo Clinic College of MedicineSophia A. Greer, Emory UniversityWalter A. Kukull, University of Washington
Language
  • English
Date
  • 2011-04
Publisher
  • Karger Publishers
Publication Version
Copyright Statement
  • © 2011 by S. Karger AG, Basel
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 1420-8008
Volume
  • 31
Issue
  • 3
Start Page
  • 239
End Page
  • 246
Grant/Funding Information
  • This work was supported by the following grants: R01 NS-050595; U01 AG-016976; P50 AG-025688; P50 AG-16574; R01 AG-15866, and the Robert H. and Clarice Smith and Abigail Van Buren Alzheimer’s Disease Research program of the Mayo Clinic Foundation.
Abstract
  • Background/Aims Evidence suggests that patients with dementia with Lewy bodies (DLB) may have more nocturnal sleep disturbance than patients with Alzheimer's disease (AD). We sought to confirm such observations using a large, prospectively collected, standardized, multicenter-derived database, i.e. the National Alzheimer's Coordinating Center Uniform Data Set. Methods Nocturnal sleep disturbance (NSD) data, as characterized by the Neuropsychiatric Inventory Questionnaire (NPI-Q), were derived from 4,531 patients collected between September 2005 and November 2008 from 32 National Institute on Aging participating AD centers. Patient and informant characteristics were compared between those with and without NSD by dementia diagnosis (DLB and probable AD). Finally, a logistic regression model was created to quantify the association between NSD status and diagnosis while adjusting for these patient/informant characteristics, as well as center. Results NSD was more frequent in clinically diagnosed DLB relative to clinically diagnosed AD (odds ratio = 2.93, 95% confidence interval = 2.22–3.86). These results were independent from the gender of the patient or informant, whether the informant lived with the patient, and other patient characteristics, such as dementia severity, depressive symptoms, and NPI-Q-derived measures of hallucinations, delusions, agitation and apathy. In AD, but not DLB, patients, NSD was associated with more advanced disease. Comorbidity of NSD with hallucinations, agitation and apathy was higher in DLB than in AD. There was also evidence that the percentage of DLB cases with NSD showed wide variation across centers. Conclusion As defined by the NPI-Q, endorsement of the nocturnal behavior item by informants is more likely in patients with DLB when compared to AD, even after the adjustment of key patient/informant characteristics.
Author Notes
  • Donald L. Bliwise, PhD, Department of Neurology, Emory University School of Medicine, Wesley Woods Health Center, 1841 Clifton Road, Room 509, Atlanta, GA 30329 (USA), Tel. +1 404 728 4751, E-Mail dbliwis@emory.edu
Keywords
Research Categories
  • Biology, Neuroscience

Tools

Relations

In Collection:

Items